INR 841.15
(6.98%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 457.83 Million INR | -25.32% |
2022 | 613.08 Million INR | 99.81% |
2021 | 306.83 Million INR | -7.55% |
2020 | 331.88 Million INR | 38.36% |
2019 | 239.86 Million INR | 21.48% |
2018 | 197.45 Million INR | 36.29% |
2017 | 144.87 Million INR | -16.94% |
2016 | 174.42 Million INR | 49.96% |
2015 | 116.31 Million INR | 13.04% |
2014 | 102.89 Million INR | 19.61% |
2013 | 86.01 Million INR | 14.81% |
2012 | 74.92 Million INR | 0.0% |
2010 | 70.5 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 149.72 Million INR | 84.75% |
2023 FY | 457.83 Million INR | -25.32% |
2023 Q4 | 162.16 Million INR | 54.91% |
2023 Q1 | 170.9 Million INR | -10.08% |
2023 Q2 | 207.94 Million INR | 21.67% |
2023 Q3 | 104.67 Million INR | -49.66% |
2022 Q3 | 168.03 Million INR | 24.38% |
2022 FY | 613.08 Million INR | 99.81% |
2022 Q1 | 119.88 Million INR | 64.9% |
2022 Q2 | 135.1 Million INR | 12.69% |
2022 Q4 | 190.06 Million INR | 13.11% |
2021 Q1 | 71.86 Million INR | -1.05% |
2021 FY | 306.83 Million INR | -7.55% |
2021 Q4 | 72.7 Million INR | -12.69% |
2021 Q3 | 83.26 Million INR | 5.39% |
2021 Q2 | 79 Million INR | 9.94% |
2020 FY | 331.88 Million INR | 38.36% |
2020 Q1 | 54.94 Million INR | 17.79% |
2020 Q2 | 93.65 Million INR | 70.46% |
2020 Q3 | 110.67 Million INR | 18.17% |
2020 Q4 | 72.62 Million INR | -34.38% |
2019 FY | 239.86 Million INR | 21.48% |
2019 Q4 | 46.64 Million INR | -32.86% |
2019 Q2 | 62.4 Million INR | 1.73% |
2019 Q1 | 61.34 Million INR | 84.95% |
2019 Q3 | 69.47 Million INR | 11.34% |
2018 Q4 | 33.16 Million INR | -49.3% |
2018 FY | 197.45 Million INR | 36.29% |
2018 Q3 | 65.42 Million INR | 0.0% |
2017 FY | 144.87 Million INR | -16.94% |
2016 Q1 | 39.46 Million INR | 0.0% |
2016 FY | 174.42 Million INR | 49.96% |
2015 FY | 116.31 Million INR | 13.04% |
2014 FY | 102.89 Million INR | 19.61% |
2013 FY | 86.01 Million INR | 14.81% |
2012 FY | 74.92 Million INR | 0.0% |
2010 FY | 70.5 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Biocon Limited | 40.9 Billion INR | 98.881% |
Blue Jet Healthcare Limited | 531.85 Million INR | 13.917% |
Concord Biotech Limited | 1.45 Billion INR | 68.635% |
Dishman Carbogen Amcis Limited | 5.14 Billion INR | 91.106% |
Jubilant Ingrevia Limited | 6.67 Billion INR | 93.136% |
Lyka Labs Limited | 599.4 Million INR | 23.619% |
Panacea Biotec Limited | 1.99 Billion INR | 77.055% |
Piramal Pharma Limited | 19.91 Billion INR | 97.701% |
SMS Lifesciences India Limited | 602.96 Million INR | 24.07% |
Supriya Lifescience Limited | 1.08 Billion INR | 57.614% |
Syngene International Limited | 5.99 Billion INR | 92.363% |
TAKE Solutions Limited | 396.91 Million INR | -15.35% |